Cell line engineering with CRISPR-Cas9: Genetic considerations
20 Oct 2020
Kevin Hemphill, R&D Scientist at Horizon Discovery, discusses the genetic considerations you should think about prior to embarking on generating a cell line using crispr including gene essentiallity, investigating copy number and the pseudogene burden of your gene of interest as well as how to deal with genes that have multiple transcripts.
About the company
Revvity Signals
Revvity Signals offers one of the most comprehensive suites of scientific software in the world. Its powerful informatics solutions are used across a spectrum of industries including Pharma and Biotech, Specialty & Agro-Chemicals, Energy & Petrochemicals, Flavors & Fragrances, Food & Beverage and Electronics. From its internationally recognized flagship ChemDraw® and E-Notebook applications, to its Signals Research Suite (Signals Notebook, Signals VitroVivo and Signals Inventa) to its exclusive TIBCO® Spotfire® partnership that brings scientific data analytics to visual life, no scientific company offers a wider range and more powerful suite of scientific solutions than Revvity Signals.
